BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21989990)

  • 1. Soluble HLA-G dampens CD94/NKG2A expression and function and differentially modulates chemotaxis and cytokine and chemokine secretion in CD56bright and CD56dim NK cells.
    Morandi F; Ferretti E; Castriconi R; Dondero A; Petretto A; Bottino C; Pistoia V
    Blood; 2011 Nov; 118(22):5840-50. PubMed ID: 21989990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression patterns of lectin-like natural killer receptors, inhibitory CD94/NKG2A, and activating CD94/NKG2C on decidual CD56bright natural killer cells differ from those on peripheral CD56dim natural killer cells.
    Kusumi M; Yamashita T; Fujii T; Nagamatsu T; Kozuma S; Taketani Y
    J Reprod Immunol; 2006 Jun; 70(1-2):33-42. PubMed ID: 16488482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NKG2A/CD94 Is a New Immune Receptor for HLA-G and Distinguishes Amino Acid Differences in the HLA-G Heavy Chain.
    Hò GT; Celik AA; Huyton T; Hiemisch W; Blasczyk R; Simper GS; Bade-Doeding C
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel mechanism of soluble HLA-G mediated immune modulation: downregulation of T cell chemokine receptor expression and impairment of chemotaxis.
    Morandi F; Ferretti E; Bocca P; Prigione I; Raffaghello L; Pistoia V
    PLoS One; 2010 Jul; 5(7):e11763. PubMed ID: 20668702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycodelin-A stimulates the conversion of human peripheral blood CD16-CD56bright NK cell to a decidual NK cell-like phenotype.
    Lee CL; Vijayan M; Wang X; Lam KKW; Koistinen H; Seppala M; Li RHW; Ng EHY; Yeung WSB; Chiu PCN
    Hum Reprod; 2019 Apr; 34(4):689-701. PubMed ID: 30597092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells.
    Jacobs R; Hintzen G; Kemper A; Beul K; Kempf S; Behrens G; Sykora KW; Schmidt RE
    Eur J Immunol; 2001 Oct; 31(10):3121-7. PubMed ID: 11592089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression and function of L-selectin on CD56bright and CD56dim natural killer cell subsets.
    Frey M; Packianathan NB; Fehniger TA; Ross ME; Wang WC; Stewart CC; Caligiuri MA; Evans SS
    J Immunol; 1998 Jul; 161(1):400-8. PubMed ID: 9647249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Different responses of CD94/NKG2A-bright and CD94/NKG2A-dim NK cell subsets isolated from patients with multiple sclerosis to interferon-beta].
    Li L; Deng YC; Zhao G
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jun; 23(6):533-5. PubMed ID: 17553351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble HLA-I-mediated secretion of TGF-beta1 by human NK cells and consequent down-regulation of anti-tumor cytolytic activity.
    Ghio M; Contini P; Negrini S; Boero S; Musso A; Poggi A
    Eur J Immunol; 2009 Dec; 39(12):3459-68. PubMed ID: 19830740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble HLA class I induces NK cell apoptosis upon the engagement of killer-activating HLA class I receptors through FasL-Fas interaction.
    Spaggiari GM; Contini P; Dondero A; Carosio R; Puppo F; Indiveri F; Zocchi MR; Poggi A
    Blood; 2002 Dec; 100(12):4098-107. PubMed ID: 12393468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells.
    Kamiya T; Seow SV; Wong D; Robinson M; Campana D
    J Clin Invest; 2019 May; 129(5):2094-2106. PubMed ID: 30860984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of NK receptors CD94 and NKG2A by T cells in rheumatoid arthritis patients in remission compared to active disease.
    Walsh CE; Ryan EJ; O'Farrelly C; Golden-Mason L; FitzGerald O; Veale DJ; Bresnihan B; Fearon U
    PLoS One; 2011; 6(11):e27182. PubMed ID: 22102879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased frequency of human leukocyte antigen-E inhibitory receptor CD94/NKG2A-expressing peritoneal natural killer cells in patients with endometriosis.
    Galandrini R; Porpora MG; Stoppacciaro A; Micucci F; Capuano C; Tassi I; Di Felice A; Benedetti-Panici P; Santoni A
    Fertil Steril; 2008 May; 89(5 Suppl):1490-6. PubMed ID: 17706207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-12-dependent inducible expression of the CD94/NKG2A inhibitory receptor regulates CD94/NKG2C+ NK cell function.
    Sáez-Borderías A; Romo N; Magri G; Gumá M; Angulo A; López-Botet M
    J Immunol; 2009 Jan; 182(2):829-36. PubMed ID: 19124726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NK cell terminal differentiation: correlated stepwise decrease of NKG2A and acquisition of KIRs.
    Béziat V; Descours B; Parizot C; Debré P; Vieillard V
    PLoS One; 2010 Aug; 5(8):e11966. PubMed ID: 20700504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activating and inhibitory receptors on synovial fluid natural killer cells of arthritis patients: role of CD94/NKG2A in control of cytokine secretion.
    de Matos CT; Berg L; Michaëlsson J; Felländer-Tsai L; Kärre K; Söderström K
    Immunology; 2007 Oct; 122(2):291-301. PubMed ID: 17521371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets.
    Yu J; Mao HC; Wei M; Hughes T; Zhang J; Park IK; Liu S; McClory S; Marcucci G; Trotta R; Caligiuri MA
    Blood; 2010 Jan; 115(2):274-81. PubMed ID: 19897577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of Fas and downregulation of CD94/NKG2A inhibitory receptors on circulating natural killer cells in patients with new-onset psoriasis.
    Son SW; Kim EO; Ryu ES; Kim TJ; Kim JN; Choi JE; Kye YC; Lee KM
    Br J Dermatol; 2009 Aug; 161(2):281-8. PubMed ID: 19438461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of KIR/NKAT2 and CD94 molecules on decidual and peripheral blood CD56bright and CD56dim natural killer cell subsets.
    Eidukaite A; Siaurys A; Tamosiunas V
    Fertil Steril; 2004 Mar; 81 Suppl 1():863-8. PubMed ID: 15019821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct binding of purified HLA class I antigens by soluble NKG2/CD94 C-type lectins from natural killer cells.
    Ding Y; Sumitran S; Holgersson J
    Scand J Immunol; 1999 May; 49(5):459-65. PubMed ID: 10320637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.